Eagle Pharmaceuticals, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2697961082
USD
0.70
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
233.56
176.45
186.01
179.17
160.76
179.14
Shareholder's Funds
233.56
176.45
186.01
179.17
160.76
179.14
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
64.00
26.92
34.26
39.66
44.41
47.78
Secured Loans
64.00
26.92
34.26
39.66
44.41
47.78
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-27.15
-18.80
-15.18
-13.67
-13.82
-11.35
Other Long Term Liabilities
5.3
4.65
5.89
4.08
0.69
3.76
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.71
Total Non-Current Liabilities
61.51
4.65
31.03
37.64
38.84
46.66
Current Liabilities
Trade Payables
18.99
16.43
6.27
5.46
9.92
11.98
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.71
Total Current Liabilities
111.09
74.38
38.09
38.82
39.69
47.30
Total Liabilities
406.16
255.48
255.12
255.64
239.29
273.11
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
7.77
7.86
8.12
10.24
5.74
9.26
Less: Accumulated Depreciation
6.60
5.96
5.19
4.32
3.35
2.44
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1.17
1.91
2.93
5.92
2.40
6.82
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
10.01
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
15.72
10.01
16.35
0.19
0.69
0.12
Total Non-Current Assets
217.41
82.88
89.06
76.19
75.45
84.41
Current Assets Loans & Advances
Current Investments
0.00
4.98
0.00
0.00
0.00
0.00
Inventories
53.26
22.85
8.73
9.03
8.30
5.12
Sundry Debtors
72.44
41.15
51.12
48.00
66.49
53.82
Cash and Bank
55.32
97.66
103.16
109.78
78.79
114.66
Other Current Assets
182.02
166.97
163.01
166.81
153.58
173.60
Short Term Loans and Advances
1.00
0.33
0.00
0.00
0.00
0.00
Total Current Assets
188.75
172.61
166.06
179.45
163.84
188.70
Net Current Assets (Including Current Investments)
77.67
98.23
127.98
140.63
124.16
141.40
Total Current Assets Excluding Current Investments
188.75
172.61
166.06
179.45
163.84
188.70
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
406.16
255.48
255.12
255.64
239.29
273.11
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
64.00
26.92
34.26
39.66
44.41
47.78
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2022 is 0.00% vs -100.00% in Dec 2021

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2022 is 13.98% vs -21.05% in Dec 2021

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2022 is -38.74% vs -34.81% in Dec 2021

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2022 is 9.35% vs 3.94% in Dec 2021

Compare Balance Sheet Results of Eagle Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
233.56
319.26
-85.70
-26.84%
Shareholder's Funds
233.56
319.26
-85.70
-26.84%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
64.00
1.38
62.62
4,537.68%
Secured Loans
64.00
1.38
62.62
4,537.68%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-27.15
0
-27.15
0.00%
Other Long Term Liabilities
5.30
3.97
1.33
33.50%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
61.51
3.97
57.54
1,449.37%
Current Liabilities
Trade Payables
18.99
4.32
14.67
339.58%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
111.09
19.13
91.96
480.71%
Total Liabilities
406.16
342.36
63.80
18.64%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
7.77
0
7.77
0.00%
Less: Accumulated Depreciation
6.60
0
6.60
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
1.17
5.11
-3.94
-77.10%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
10.01
0
10.01
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
15.72
2.61
13.11
502.30%
Total Non-Current Assets
217.41
7.72
209.69
2,716.19%
Current Assets Loans & Advances
Current Investments
0
268.31
-268.31
-100.00%
Inventories
53.26
0
53.26
0.00%
Sundry Debtors
72.44
0
72.44
0.00%
Cash and Bank
55.32
59.82
-4.50
-7.52%
Other Current Assets
182.02
328.13
-146.11
-44.53%
Short Term Loans and Advances
1.00
0
1.00
0.00%
Total Current Assets
188.75
334.64
-145.89
-43.60%
Net Current Assets (Including Current Investments)
77.67
315.51
-237.84
-75.38%
Total Current Assets Excluding Current Investments
188.75
334.64
-145.89
-43.60%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
406.16
342.36
63.80
18.64%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
64.00
1.38
62.62
4,537.68%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 56.22 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 0.00% vs -100.00% in Dec 2021

Annual - Other Long Term Liabilities
Other Long Term Liabilities 5.30 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 13.98% vs -21.05% in Dec 2021

Annual - Fixed Assets
Fixed Assets 1.17 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -38.74% vs -34.81% in Dec 2021

Annual - Investments
Investments 10.01 Million
in Dec 2022

Figures in Million
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 188.75 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 9.35% vs 3.94% in Dec 2021